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RESEARCH ARTICLE
Dynamic coupling of ALCAM to the actin cortex strengthens cell
adhesion to CD6
Joost te Riet1,2,*, Jonne Helenius2, Nico Strohmeyer2, Alessandra Cambi1, Carl G. Figdor1 and Daniel J. Mu¨ller2,*
ABSTRACT
At the immunological synapse, the activated leukocyte cell
adhesion molecule (ALCAM) on a dendritic cell (DC) and CD6
molecules on a T cell contribute to sustained DC–T-cell contacts.
However, little is known about how ALCAM–CD6 bonds resist and
adapt to mechanical stress. Here, we combine single-cell force
spectroscopy (SCFS) with total-internal reflection fluorescence
microscopy to examine ALCAM–CD6-mediated cell adhesion. The
combination of cells expressing ALCAM constructs with certain
cytoplasmic tail mutations and improved SCFS analysis processes
reveal that the affinity of ALCAM–CD6 bonds is not influenced by
the linking of the intracellular domains of ALCAM to the actin cortex.
By contrast, the recruitment of ALCAM to adhesion sites and the
propensity of ALCAM to anchor plasma membrane tethers depend
on actin cytoskeletal interactions. Furthermore, linking ALCAM
to the actin cortex through adaptor proteins stiffens the cortex
and strengthens cell adhesion. We propose a framework for how
ALCAMs contribute to DC–T-cell adhesion, stabilize DC–T-cell
contacts and form a mechanical link between CD6 and the actin
cortex to strengthen cell adhesion at the immunological synapse.
KEY WORDS: Single-cell force spectroscopy, Atomic force
microscopy, ALCAM, CD6, Cell adhesion, Immunological synapse,
Membrane tethers
INTRODUCTION
Cell adhesion molecules (CAMs) mediate cell attachment and play
important roles in tissue organization by facilitating cohesion,
development, transmembrane signaling and cell motility. Cell
adhesion is tightly regulated and depends on the expression level,
conformation (affinity) and distribution (avidity) of adhesion
receptors in the plasma membrane (Carman and Springer, 2003).
Cells regulate CAM avidity and/or affinity through interactions with
the actin cytoskeleton (Schwarz and Gardel, 2012). Several CAMs,
such as cadherins and integrins, transduce externally applied
forces through the cytoskeleton into the cell to initiate different
biochemical signals; a process called mechanotransduction
(Schwarz and Gardel, 2012).
The activated leukocyte cell adhesion molecule (ALCAM, also
known as CD166) is a type I transmembrane protein of the
immunoglobulin superfamily of CAMs (Bowen et al., 1995).
Homotypic ALCAM–ALCAM trans-interactions are associated
with cell migration and metastasis in many types of tumors (van
Kempen et al., 2001, for a review see Weidle et al., 2010).
Heterotypic interactions of ALCAM expressed by dendritic cells
(DCs) with cluster of differentiation 6 (CD6) expressed by T cells
play a role during T cell activation (Bowen et al., 1995; Hassan
et al., 2004; Zimmerman et al., 2006). Upon establishing DC–T-
cell contact, both ALCAM and CD6 are recruited to the highly
organized interface of the immunological synapse (Gimferrer
et al., 2004; Dustin, 2007). At the immunological synapse, DCs
present antigens to T cells and thereby start an antigen-specific
immune response. Intravital microscopy studies indicate that,
within lymphoid tissue, naı¨ve T cells scan DCs for antigen
presenting sites at speeds of up to 0.5 mm/s (Mempel et al., 2004)
and experience shear stresses of<0.05 N/m2 (Woolf et al., 2007).
The ability to withstand shear is, therefore, essential for
establishing and maintaining DC–T-cell contacts. In vitro and
confocal microscopy studies show that DC–T-cell contacts are
stabilized by bonds that form between the intercellular adhesion
molecule-1 (ICAM-1) and lymphocyte function-associated
antigen-1 (LFA-1, an integrin dimer consisting of an a and b
chain encoded by ITGAL and ITGB2, respectively) as well as
between ALCAM and CD6 (Zimmerman et al., 2006; Dustin,
2007). ICAM-1–LFA-1 bonds mainly contribute to the initial,
antigen-independent adhesion of DCs and T cells, whereas
ALCAM–CD6 bonds prolong cell–cell contacts and are needed
for optimal DC–T-cell stimulation (Hassan et al., 2004;
Zimmerman et al., 2006) and to facilitate strong cell adhesion
under mechanical stress (te Riet et al., 2007). These insights and
quantification of ALCAM–CD6 bonds, by using atomic force
microscopy (AFM)-based single-cell force spectroscopy (SCFS)
assays (Helenius et al., 2008), have led to the hypothesis that
ALCAM–CD6 bonds stabilize DC–T-cell contacts by resisting
shear stress and facilitating adhesion from the antigen-recognition
step onwards. However, the molecular mechanisms by which DCs
regulate ALCAM adhesion at the immunological synapse remain
to be investigated.
Cell adhesion and biochemical assays show dynamic
interactions between ALCAM and the actin cytoskeleton
(Nelissen et al., 2000; Zimmerman et al., 2004; te Riet et al.,
2007). For example, activation of the actin cytoskeleton, by using
low concentrations of cytochalasin D, strengthens cell adhesion
(Nelissen et al., 2000; Zimmerman et al., 2004). Although
ALCAM lacks a direct actin-binding site (Zimmerman et al.,
2004), its cytoplasmic tail can interact, via adaptor proteins, with
the actin cortex (Fehon et al., 2010). The short cytoplasmic tail of
ALCAM contains a positive-charge-rich domain (PCRD) at
the membrane proximal site and a KTEA peptide motif at
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the C-terminus (Fig. 1A). The PDZ domain of the adaptor
protein syntenin-1 recognizes the class I PDZ-binding
motif KTEA (Grootjans et al., 1997; Gimferrer et al., 2005;
Beekman and Coffer, 2008; C. Tudor, J.t.R., R. Harkes, J. S.
Kanger, C.G.F. and A.C., unpublished), whereas the ezrin-
radixin-moesin (ERM) family of adaptor proteins can link CAMs
to actin through the PCRD (Yonemura et al., 1998; Barreiro et al.,
2002). Specifically, ALCAM seems to associate with ezrin
(C. Tudor, J.t.R., R. Harkes, J. S. Kanger, C.G.F. and A.C.,
unpublished). However, whether the adaptor proteins ezrin and
syntenin-1 regulate and strengthen ALCAM–CD6-mediated cell
adhesion remains unclear.
To investigate how ALCAM–CD6 bonds establish cell
adhesion and the role of the actin cytoskeleton in strengthening
this adhesion, we used SCFS on K562 cells that express ALCAM
constructs with specific cytoplasmic tail mutations. By combining
AFM and optical microscopy, cells attached to an AFM cantilever
could be imaged while measuring the mechanical interactions
of the cell with functionally active substrates. The ALCAM
constructs in combination with new procedures to analyze
SCFS data and total-internal reflection fluorescence microscopy
(TIRFM) allowed determination of the molecular mechanisms
that contribute to the regulation of ALCAM–CD6-mediated cell
adhesion. We observed that most ALCAMs were linked to the
actin cortex; however, a considerable amount of unlinked
ALCAMs adhered through the formation of membrane tethers.
The experiments show that mechanically stressing ALCAM–CD6
bonds does not affect bond affinity but stiffens the actin cortex.
Furthermore, linking ALCAM to the actin cortex by adaptor
proteins influences ALCAM recruitment to the substrate, tightens
the cellular contact with the substrate and lowers the number of
membrane tethers formed. Altogether, the data suggest a
Fig. 1. Analysis of ALCAM constructs with cytoplasmic tail mutations by using SCFS. (A) ALCAM binds to CD6 through its outer Ig domain to the
membrane-proximal domain of CD6 (top). A zoom into the cytoplasmic tail of ALCAM-WT (bottom) shows the PCRD at the membrane proximal position and
the KTEA-binding motif at the C-terminus, which is the PDZ-domain binding site. Asterisks indicate the positions of threonine to alanine mutations for
ALCAM-DThr. ALCAM-GPI has no cytoplasmic tail but a GPI-anchor. (B) Colocalization of the different ALCAM constructs with syntenin-1 and ezrin, as
determined by confocal microscopy (supplementary material Fig. S2), by means of Manders’ coefficient (15full colocalization and 05none; ***P,0.0001; n.s.,
not significant). (C) The adhesion of a K562 cell immobilized on a ConA-coated cantilever is probed by positioning the cell over one of four openings in a thin
PDMS mask on glass (i). Subsequently, the cell is brought into contact with a control coating, i.e. BSA (black), GaHuFc (green), ICAM-1-Fc (blue) or the
ALCAM-specific ligand-coating CD6-Fc (red) (coating quality see supplementary material Fig. S1B). During the approach (denoted by black arrows, black
approach curve in D), the cell is pressed onto the substrate until reaching a preset force of <2 nN (ii). After a preset contact time ranging from 0.5 to 120 s, the
cell is retracted from the substrate (marked by red arrows, red retract curve in D) and a force–distance curve is recorded (D). This force–distance curve
corresponds to a cell adhesion signature. As the strain on the cell increases, bonds formed between the cell and substrate break sequentially (iii) until the cell
and substrate are completely separated (iv). (D) The maximum adhesive force exerted on the cantilever is referred to as the detachment force. The cell stiffness
is determined by fitting the contact region (green dashed line) of the approach force–distance curve. During the separation of the cell from the substrate,
two types of molecular unbinding events occur. First, cell surface receptors remain anchored to the cell cortex and unbind as the force increases [denoted as
jump (J)-events]. The second type of unbinding events occurs when membrane tethers are pulled out of the cell with characteristic long plateaux of constant
force [denoted as tether (T)-events].
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mechanical framework for how ALCAM–CD6-mediated cell
adhesion stabilizes DC–T-cell contacts.
RESULTS
Characterization of ALCAM constructs with different
actin-linking capabilities
Heterotypic ALCAM–CD6 cell adhesion is regulated by the actin
cytoskeleton (te Riet et al., 2007). However, whether actin linking
modulates ALCAM remains unclear. To give further insight into
this process, we used non-adherent K562 cells stably transfected
with different ALCAM constructs (Fig. 1A). These constructs
were wild-type (WT) ALCAM (ALCAM-WT), ALCAM-WT
with enhanced green fluorescent protein (eGFP) fused to the
intracellular C-terminus using a 5-amino-acid linker (ALCAM-
GFP), ALCAM with two threonine residue to alanine residue
mutations, T556A and T581A, the latter of which is in the PDZ-
binding motif at the cytoplasmic tail (ALCAM-DThr), and a
glycosylphosphatidylinositol (GPI)-anchored form of ALCAM
that lacks the transmembrane and cytoplasmic domain (ALCAM-
GPI) (see Fig. 1A). The adaptor protein syntenin-1 is thought to
bind to the KTEA motif at the PDZ-binding site (Grootjans et al.,
1997; Beekman and Coffer, 2008; C. Tudor, J.t.R., R. Harkes,
J. S. Kanger, C.G.F. and A.C., unpublished) of the cytoplasmic
tail of ALCAM, whereas the ERM family member ezrin binds to
the PCRD at the membrane-proximal position (Fig. 1A)
(Yonemura et al., 1998; C. Tudor, J.t.R., R. Harkes, J. S.
Kanger, C.G.F. and A.C., unpublished). Therefore, we predicted
that the mutation T581A in ALCAM-DThr would influence the
binding of syntenin-1, whereas ALCAM-GPI would bind to
neither syntenin-1 nor ezrin. Indeed, confocal microscopy
revealed less colocalization of ALCAM-DThr or ALCAM-GPI
with either syntenin-1 or actin, whereas ALCAM-GPI did not
colocalize with ezrin (Fig. 1B; supplementary material Fig.
S2A,B). As expected, because the positive charge of the PCRD
remained unaltered, the T556A mutation in the PCRD did not
influence ezrin binding (Fig. 1B). Furthermore, it is unlikely that
the mutation T556A, which is located close to the membrane and
in a motif not known for PDZ binding, would influence binding
of syntenin-1 (Beekman and Coffer, 2008). Fluorescence-
activated cell sorting analysis showed that K562 cells transfected
with each of the ALCAM constructs expressed similar levels of
ALCAM at their surface, whereas untransfected K562 cells did
not express ALCAM (supplementary material Fig. S1D). Thus,
we can exclude that different expression levels account for the
lack of colocalization of ALCAM with cytoskeletal proteins.
Probing ALCAM–CD6-mediated cell adhesion of different
ALCAM constructs
Having observed that the ALCAM constructs show different
degrees of actin linking, we examined ALCAM-mediated
adhesion to CD6. Hereto, it was necessary to discriminate
between the contribution of specific ALCAM–CD6-mediated and
unspecific interactions to cell adhesion. Therefore, we improved
the SCFS assay by using four-segment PDMS masks in glass
Petri dishes (Fig. 1C). To quantify cell adhesion, a single K562
cell expressing ALCAM, attached to an AFM cantilever, was
brought into contact with various substrates (supplementary
material Fig. S1A,B) for predefined contact times. By probing
unspecific and specific ligand-coated substrates with the same cell,
the strength of unspecific adhesion to bovine serum albumin
(BSA), goat anti-human-Fc (GaHuFc) and to ICAM-1-Fc – a
ligand for which K562 cells do not express receptors – was
determined (Fig. 1C; supplementary material Fig. S1C).
Thereafter, the specific ALCAM–CD6-mediated cell adhesion
to CD6-Fc-coated substrates was examined. The adhesive
interactions between the cell and substrate were recorded in
force–distance curves (Fig. 1D), the shape of which gives insight
into the de-adhesion process (Friedrichs et al., 2010). Averaged
force–distance curves of specific ALCAM–CD6-mediated
interactions differ, both in shape and depth, from those of K562
cells adhering to unspecific substrates (BSA, GaHuFc or ICAM-1-
Fc) and untransfected K562 cells (Fig. 2A; supplementary material
Fig. S1E). To characterize the adhesion strength of the cell, the
maximum detachment force was determined (Fig. 1D). Fig. 2B
shows that the detachment forces of cells expressing each of the
ALCAM constructs bound to control substrates and control K562
cells bound to CD6 were low (0.7560.34 nN; mean6s.d.). This
unspecific detachment force constitutes the background adhesion
of K562 cells. By contrast, the detachment forces of K562 cells
expressing ALCAM constructs that adhere to CD6, ranging from
2.2460.84 nN to 3.2861.21 nN, were significantly higher.
Therefore, we conclude that specific ALCAM–CD6-mediated
adhesion accounts for 66–77% of the detachment force and, thus,
the majority of the interactions between ALCAM-expressing cells
and CD6.
Contact-time-dependent detachment forces reveal the
dynamics of ALCAM–CD6-mediated avidity
To contribute to cell adhesion CAMs must be at, or move to, the
contact site. In the case of ALCAM, the actin cytoskeleton is
implicated in receptor movement at the plasma membrane
(Zimmerman et al., 2004; te Riet et al., 2007). To study
ALCAM dynamics, we measured the detachment forces of K562
cells expressing different ALCAM constructs after contact times
spanning 0.5–120 s. For all cell types, the detachment force (i.e.
adhesion) increased with contact time (Fig. 2C). A plot of the
mean (6s.e.m.) detachment forces over contact time (Fig. 2D)
showed that after 120 s of contact the cell adhesion reached a
plateau. In the case of specific adhesion to CD6, K562-ALCAM-
WT cells adhered with 4.760.3 nN, K562-ALCAM-GFP cells
with 5.860.4 nN, K562-ALCAM-DThr cells with 6.460.4 nN
and K562-ALCAM-GPI cells with 5.460.3 nN. In comparison,
control K562 cells showed much lower detachment forces of
1.560.1 nN. Because untransfected K562 cells cannot adhere
specifically to CD6, we considered their adhesion to be unspecific
background. To describe the specific component of ALCAM-
mediated cell adhesion, we subtracted this unspecific adhesion
component from the detachment forces of cells that express
ALCAM (Fig. 2E). Fitting the normalized detachment force
with single exponential functions (Fig. 2E) showed that the
time-dependent increase in adhesion of ALCAM-GPI and
ALCAM-DThr to the CD6 substrate was 2.8 and 1.8 times
faster, respectively, than ALCAM-WT (Table 1). Because K562-
ALCAM-GFP and K562-ALCAM-WT cells showed similar
adhesion dynamics, the interactions of ALCAM are unaffected
by fusion the GFP tag to the C-terminus.
AFM-TIRFM shows one-by-one unbinding of membrane
tethers from CD6
Upon detachment of a cell from a substrate, the CAMs and their
linkages to the actin cortex rearrange. To gain insight into this
process we detached a single K562-ALCAM-GFP cell from the
CD6 substrate using AFM-based SCFS while imaging the cell–
substrate contact region by TIRFM. After being in contact with
RESEARCH ARTICLE Journal of Cell Science (2014) 127, 1595–1606 doi:10.1242/jcs.141077
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the substrate for 5 s, the cell was detached upon retracting the
cantilever for 20 s over a distance of 100 mm. This detachment
process was recorded in a force–time curve (Fig. 3A) and by a
continuous series of TIRFM images at 200 ms/image (Fig. 3B;
supplementary material Movie 1). The force–time curve and
TIRFM analyses showed that the cell remained partially attached
to the substrate, whereas the cell body separated tens of
micrometers from the substrate. The TIRFM movies revealed
that after the unbinding of the cell body, fluorescent extensions
of the plasma membrane remained attached to the substrate
for several seconds (supplementary material Movies 1–3). These
extensions are membrane tethers (Helenius et al., 2008; Krieg
et al., 2008) and can be observed as filamentous structures on
the substrate (Fig. 3C; supplementary material Movie 2, 3).
Retraction of the cantilever applies an outward force to the
ALCAM–CD6 bonds, which anchor the membrane tether to the
substrate. Consequently, the membrane tethers are extended
until the bond ruptures, the tether withdraws to the cell body and
Fig. 2. Dependence of the cellular
detachment force on contact time.
(A) Averaged force–distance curves of
cells expressing ALCAM-WT (left,
NFD§52, NC513) or control K562 cells
(right, NFD§34, NC510) adhering for 10 s
to CD6-Fc (red), BSA (black), GaHuFc
(green) or ICAM-1-Fc-coated (blue)
substrates. The curves highlight the
different detachment characteristics of the
cells on each of the substrates. Force–
distance curves were aligned at their
maximum force and averaged. Control
force–distance curves (BSA, GaHuFc and
ICAM-1-Fc) look very similar in shape,
whereas specific force–distance curves
detecting the detachment of ALCAM-WT
cells from CD6-Fc show stronger – e.g.
deeper – and wider adhesion. (B) Box-
whisker plots of the detachment forces of
cells expressing ALCAM-WT, -GFP, -DThr
or -GPI or control K562 cells (NC§10) after
10 s contact time with CD6-Fc, BSA,
GaHuFc or ICAM-1-Fc-coated substrates.
Numbers in angle brackets give the
number of force–distance curves analyzed
for each condition. ***P,0.0001. The box
indicates the 25–75% quartiles, the center
line represents the median and the square
represents the mean. (C) With increasing
contact time to CD6-Fc-coated substrates,
the detachment force of single cells
expressing ALCAM-WT, -GFP, -DThr or
-GPI or control K562 cells increases.
(D) Mean (6s.e.m.) detachment forces of
K562 cells from CD6 increase with contact
time and approach a plateau. Dashed
curves show single exponential fits to the
data. (E) Normalized detachment forces of
K562 cells expressing different ALCAM
constructs and adhering to CD6. Fitting the
data (dashed curves) extracts binding
rates of ALCAM-expressing cells to CD6
(see Table 1). Data in D and E was
extracted from that shown in C.
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the force applied to the cantilever drops indicating a tether (T)-
event (Fig. 1D). In the force–time curve (Fig. 3B), some
unbinding events can be attributed to the detachment of
ALCAM-GFP-containing membrane tethers from the substrate
in the simultaneously recorded TIRFM images (indicated by the
numbered arrows in Fig. 3A,B; supplementary material Fig. S3).
Unbinding events in force–distance curves might be lacking
from TIRFM images for several reasons, including bleached
GFP molecules, insufficient optical sensitivity and a low signal-
to-noise ratio. It has been debated whether T-events recorded by
SCFS (Fig. 1D) represent the unbinding of CAMs that anchor the
membrane tethers to the substrate (Helenius et al., 2008). The
combined SCFS and TIRFM data show that this is, indeed, the
case.
Adhesion time and cytoskeletal linking modulate
ALCAM-mediated membrane tethering
The observation that cells expressing K562-ALCAM-GFP exploit
membrane tethers to adhere to CD6 over distances of tens of
micrometers prompted us to study this adhesion mechanism in
more detail. In particular, we were interested in the influence of
the actin cytoskeleton interactions on tether dynamics. When
Table 1. Rates of increase in detachment force and tethering rates for the different ALCAM constructs expressed in K562 cells
ALCAM-expressing cell line
tK (s)
R2
tK (s)
R2(detachment force)a (tethering)
K562-ALCAM-WT 41.5610.8 0.968 45.6610.8 0.976
K562-ALCAM-GFP 41.268.7 0.979 39.366.7 0.985
K562-ALCAM-DThr 23.662.5 0.992 18.766.9 0.906
K562-ALCAM-GPI 14.762.9 0.970 12.762.6 0.968
Control K562 cells 15.862.5 0.981 21.962.8 0.989
Fits to the data given in Fig. 2E and Fig. 4C resulted in exponential time constants, tK, for the different ALCAM constructs with an accuracy given by adjusted R
2.
aRate for control K562 cells from Fig. 2D. Results are mean6s.d.
Fig. 3. Combining SCFS with time-lapse TIRFM
correlates the unbinding of individual tethers to cell
adhesion events. (A) Force–time (black) and height–time
(red) curves recorded upon the approach to and withdrawal
from the CD6-Fc-coated substrate of a K562 cell expressing
ALCAM-GFP while recording a continuous stream of TIRFM
images. The section of the force–time curve where
unbinding events occur (gray rectangle) is shown in detail
(bottom), with a subset of unbinding events marked
(numbered arrows). (B) Selection of TIRFM images
recorded while retracting the ALCAM-GFP cell from the
CD6-Fc substrate. The release of tethers can be
simultaneously observed in TIRFM images and force–time
curve as indicated by the numbered arrows. (C) False-color
images from supplementary material Movie 2 (top) and
Movie 3 (bottom) at the moment that the cellular body loses
contact or just has lost contact, respectively, with
the substrate.
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ALCAM molecules are displaced far from the cell body they
cannot be bound to the actin cortex. Therefore, we assumed that
most, if not all, of the force recorded after separating the main
cell body from the substrate by .10 mm is generated by
membrane tethers. Accordingly, we counted the number of T-
events that occurred .10 mm after reaching the maximum
detachment force (Fig. 1D). For K562 cells expressing the
different ALCAM constructs, the number of T-events increased
with contact time (Fig. 4A). Strikingly, after 10 s of contact
considerably more T-events were present for K562 cells that
expressed ALCAM-GPI (14.161.1; mean6s.e.m.) compared
with cells expressing ALCAM-WT (5.660.5), -GFP (5.260.4)
or -DThr (7.460.7). For untransfected K562 cells, as well as for
all control substrates (BSA, GaHuFc and ICAM-1-Fc), the
number of T-events was much lower, suggesting a background
level of around 2.862.4 (6s.d.) T-events per retraction (Fig. 4B).
This level of background tethering implies that <52% (ALCAM-
WT or ALCAM-GFP cells), <61% (ALCAM-DThr cells) and
<80% (ALCAM-GPI cells) of the T-events are mediated by
ALCAM bonds.
Fig. 4. Intracellular assembly of
ALCAM modulates the formation of
membrane tethers in cell adhesion.
(A) Box-whisker plots of T-events
observed per retraction of a K562 cell
expressing either ALCAM-WT, ALCAM-
GFP, ALCAM-DThr, ALCAM-GPI or no
ALCAM (control) from CD6-Fc substrates
(NC§10, numbers given in brackets show
the number of force–distance curves
analyzed). The box indicates the 25–75%
quartiles, the center line represents the
median and the square represents the
mean. (B) Mean number (6s.e.m.) of T-
events detected per retraction of a cell
from CD6-Fc, BSA, GaHuFc or ICAM-1-
Fc substrates after a contact time of 10 s.
(C) The mean number of T-events per
retraction depends on contact time and is
fitted with a single exponential fit (dashed
lines, values are given in Table 1).
(D) Decay curves showing the position
(distance) at which T-events occur for
contact times of 2 (left) or 120 s (right). All
T-events from the data set displayed in A
are merged. (E) Histograms of tether
forces from T-events at short contact
times (merged data of 0.5, 2 and 5 s
contact time, left panel) show similar
distributions for K562 cells expressing
ALCAM-WT, ALCAM-GFP, ALCAM-DThr
or ALCAM-GPI and for control K562 cells.
For long contact times (merged data of 50
and 120 s, right panel) a shift is observed
for K562 cells expressing ALCAM.
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Next, we plotted the mean number of T-events against the
contact time of the cell with the CD6 substrate (Fig. 4C). Cells
expressing GPI-anchored ALCAM had almost twice as many T-
events as cells expressing the other ALCAM constructs. An
explanation for this behavior is that the GPI-anchored ALCAM
lacks a cytoplasmic domain (Nelissen et al., 2000) that can be
linked to the actin cortex (Fig. 1B). To determine how tethering
develops with contact time, the number of tethers at increasing
contact time with the substrate was fitted with single exponential
functions (Fig. 4C). Surprisingly, the rates at which the number
of tethers increased for cells expressing each of the ALCAM
constructs were similar to the rates of detachment force (Table 1).
Although membrane tethering contributes only a minor part
to total cell adhesion, a weak correlation between cell detachment
force and the number of tethers per cell was found
(supplementary material Fig. S4B). Therefore, we conclude that
both the number of tethers and detachment force correlate to the
number of ALCAM molecules bound to CD6, which increase
with cell–substrate contact time.
Neither ALCAM distribution nor repetitive contacts influence
cell adhesion
Stable expression of different ALCAM constructs in non-adherent
K562 cells reduced the complexity of the system by modulating
expression levels and cellular background adhesion. However, the
ALCAM constructs show different degrees of actin linking, which
might influence the distribution of ALCAM on the plasma
membrane and alter cell adhesion to CD6 by changing avidity
and membrane tether formation. In particular, a difference in the
distribution of GPI-anchored ALCAMs might be expected because
they reside in GPI-enriched lipid domains (van Zanten et al., 2009).
The tetraspanin family member CD9 might also influence the
micro-organization of ALCAM at the plasma membrane through
interaction with the extracellular Ig domain of ALCAM (Gilsanz et
al., 2013). However, when imaged at the resolution of the confocal
microscope (<0.25 mm), all ALCAM constructs showed similar
distributions in microdomains of <0.2 mm2 and colocalized with
CD9 (supplementary material Fig. S2C,D). Therefore, we excluded
the possibility that differences in ALCAM distribution contributed
to our cell adhesion measurements.
It might be speculated that GPI-anchored or single
transmembrane-anchored ALCAMs are extracted from the
membrane during detachment of the cell from the substrate.
However, extracting a GPI-anchored molecule that resides in the
outer leaflet of the membrane (Cross et al., 2005) or a single
transmembrane domain (Oesterhelt et al., 2000) from the membrane
requires forces .100 pN, which are higher than the average tether
forces ranging between 25 and 50 pN (Fig. 4E). Moreover, repeated
detachment of a cell expressing ALCAM-GPI from a substrate with
delay times equal to or longer than contact times had no effect on
ALCAM-specific detachment forces (supplementary material Fig.
S4A). This demonstrates that when delay times are used between
sequential adhesion cycles, the cell adhesion shows no memory of
previous adhesion events (Zarnitsyna et al., 2007; Friedrichs et al.,
2010; Dao et al., 2013). Therefore, repetitive cell adhesion
measurements were treated as uncorrelated events.
Unbinding kinetics of the ALCAM–CD6 bond
Membrane tethers are native force clamps because they maintain
a near constant force as they are pulled out of the plasma
membrane (Sheetz, 2001). The tether force depends on the
properties of the plasma membrane and actin cortex, and the
speed at which they are pulled, but not on the bond anchoring the
tether to the substrate (Hochmuth et al., 1996; Krieg et al., 2008).
However, the lifetime of the tether depends on the strength of the
receptor–ligand bond and reflects the unbinding properties of the
bond (Krieg et al., 2008). To analyze the unbinding kinetics of
ALCAM–CD6 bonds, we plotted the mean number of T-events
against pulling distances (Fig. 4D). These decay curves depict the
unbinding rate of bond(s) that anchor the tethers. To determine
the unbinding rate after short (2 s) and long (120 s) contact times
with the CD6 substrate, the decay curves were fitted with
simple exponential decay functions (Fig. 4D). The resulting
decay constants (dK) were divided by the retraction speed
(5 mm/s) to reveal the mean lifetime of the ALCAM–CD6
bond(s), from which the reciprocal describes the unbinding rate
(koff, Table 2). Strikingly, we found almost equal unbinding rates
for cells expressing each of the ALCAM constructs with the koff
determined after 2 s of contact time being almost twice as large
as those determined after 120 s (Table 2). This might be because,
after a contact time of 2 s, most tethers are anchored to the
substrate by only one ALCAM–CD6 bond, whereas at 120 s
multiple ALCAM–CD6 bonds anchor single membrane tethers. If
multiple bonds share the load of a membrane tether, the lifetime
of the tether increases (Evans and Calderwood, 2007).
The finding that the cells expressing each of the ALCAM
constructs have the same unbinding rate of membrane tethers,
koff, does not dictate that unstressed dissociation rates at
equilibrium (k0off) are also the same because, as stipulated by
the Bell model of force induced unbinding, the unbinding rate
depends on the applied force (i.e. force loading rate) (Bell, 1978).
Therefore, tether forces were examined. Histograms of tether
forces recorded after short contact times (0.5–5 s) showed
overlapping peaks (Fig. 4E, left panel) with mean tether forces
for K562 cells expressing ALCAM-WT of 34.769.1 pN
(maximum6s.d.), ALCAM-GFP of 41.8610.7 pN, ALCAM-
DThr of 37.469.8 pN, ALCAM-GPI of 36.4612.6 pN. The
mean tether force for untransfected cells was 29.169.9 pN. The
similar tether forces suggest that, independent of the ALCAM
construct, the membrane tethers pulled from K562 cells have
similar mechanical properties. Taken one step further, this means
that the unbinding rate of ALCAM–CD6 bonds that anchor
membrane tethers is independent of the transmembrane and
intracellular ALCAM domain.
After long contact times (50–120 s; Fig. 4E, right panel), the
mean tether force increased to 45.8616.8 pN for ALCAM-WT,
53.4612.1 pN for ALCAM-GFP, 46.4615.2 pN for ALCAM-
DThr, 40.6613.2 pN for ALCAM-GPI and 31.368.6 pN for
untransfected K562 cells. With the exception of the control
K562 cells and ALCAM-GPI cells, there was a marked contact-
time-dependent increase of the tether forces (see supplementary
material Fig. S4C for trends). The simultaneous unbinding of
multiple membrane tethers does not explain this increase. For
the stronger-tethering K562-ALCAM-GPI cells, the simultaneous
unbinding of two membrane tethers is indicated by a second force
peak, which became prominent with increasing contact time
(supplementary material Fig. S4C). However, for cells expressing
the other ALCAM constructs, we speculate that contact-time-
dependent changes in cortical actin alter cortex properties and, thus,
the tether forces. Nevertheless, based on the near identical unbinding
rates at similar unbinding forces (Table 2 and Fig. 4E), our data
shows that the linking of ALCAM to the actin cortex through the
cytoplasmic tail does not alter the affinity (unbinding rate) of the
extracellular ALCAM domain for CD6.
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The contribution of ALCAM-mediated membrane tethers to
cell adhesion
Using the mean tether force (Fig. 4E), the number of tethers
events per retraction (Fig. 4D) and the mean detachment force
(Fig. 2C), we estimated the contribution of membrane tethers to
the adhesion formed between cell and substrate. The number of
membrane tethers at distance 0 mm (i.e. at maximum detachment
force) were extrapolated from the exponential fits and multiplied
by the mean tether force. The product was compared with the
total detachment force showing that membrane tethers accounted
for 16.3%62.6 for ALCAM-WT, 14.8%61.6 for ALCAM-GFP,
14.1%61.1 for ALCAM-DThr and 27.9%60.5 for ALCAM-GPI
to the total adhesion of the cell (mean6s.d.), independent of
contact time. Thus, tethers contribute considerably to ALCAM–
CD6-mediated cell adhesion.
ALCAM attaches and modulates the actin cortex
Our SCFS experiments showed that the shape of the force–
distance curves depends on which ALCAM construct the K562
cells expressed. To reveal common features, force–distance
curves of all constructs and contact times were aligned at
their maximum detachment force and averaged (Fig. 5A;
supplementary material Fig. S5A). First, comparison of
K562-ALCAM-GPI cells with K562-ALCAM-WT cells for
distances .7.5 mm showed how tethering influenced the shape
of the averaged force–distance curve (Fig. 5A). Second, the
Table 2. Decay rate and dissociation constants determined from tether distribution plots
ALCAM-expressing cell line dK (mm) at 2 s koff (s21) at 2 s dK (mm) at 120 s koff (s21) at 120 s
K562-ALCAM-WT 10.360.2 0.48760.010 17.260.1 0.29060.002
K562-ALCAM-GFP 10.160.2 0.49660.011 15.860.1 0.31760.002
K562-ALCAM-DThr 10.860.1 0.46260.006 19.160.1 0.26260.002
K562-ALCAM-GPI 10.260.1 0.48960.004 18.360.1 0.27360.001
Control K562 cells 21.362.7 0.23460.030 19.160.2 0.26160.003
A fit to the data given in Fig. 4D allowed to approach the exponential constants, dK, of different ALCAM constructs. These exponential constants were used to
determine the unbinding rates, koff, of the CD6-specific bonds formed by each ALCAM construct (see text). Results are mean6s.e.m.
Fig. 5. ALCAM binding to the actin cortex strengthens cell adhesion and modulates cell stiffness upon CD6 binding. (A) Averaged force–distance curves of
K562 cells expressing ALCAM-WT, ALCAM-GFP, ALCAM-DThr or ALCAM-GPI (NC§10) were generated by averaging NFD§52 (exact numbers are given in angle
brackets) of 50 s contact time. For averaging, force–distance curves were aligned on the maximum detachment peak. (B) The elasticity for cells expressing the
different ALCAM constructs at different contact times was measured by fitting the linear slope – e.g. contact region – of the averaged retraction force–distance curves
presented in supplementarymaterial Fig. S5B. The elasticity (6s.e.m.) of K562 cells expressing ALCAM-WTand ALCAM-GFP increases upon longer contact time with
CD6, whereas it stays nearly the same for K562 cells expressing ALCAM-DThr or ALCAM-GPI (within a range of 1–2 nN/mm, indicated by the gray shaded area).
(C) Box-whisker plots of the cell stiffness (i.e. resistance to deformation) extracted by linearly fitting the contact region of the approach force–distance curves, the last
eight curves before first contact with CD6-Fc and number 6–12 thereafter. K562 cells (NC§10) expressing ALCAM-WT, ALCAM-GFP or ALCAM-DThr stiffen
significantly after contact with CD6 in contrast with cells expressing ALCAM-GPI and control K562 cells. ***P,0.0001; n.s., not significant. The box indicates the
25–75% quartiles, the center line represents the median and the square represents the mean.
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force–distance curves recorded for K562-ALCAM-WT cells or
K562-ALCAM-GFP cells were steeper before the maximum
detachment force than those of K562-ALCAM-DThr cells or
K562-ALCAM-GPI cells. Fitting these linear slopes revealed cell
elasticities of 3.060.2 nN/mm for ALCAM-WT, 3.060.1 nN/mm
for ALCAM-GFP, 1.860.1 nN/mm for ALCAM-DThr, and
1.660.1 nN/mm for ALCAM-GPI (mean6s.e.m.). Note that
lower values indicate a higher deformability of the cell. An
explanation for the almost twofold difference in elasticity
between the cells expressing ALCAM-WT and -GFP, and those
expressing the mutated ALCAM forms is that the cytoplasmic tail
of ALCAM-WT (and ALCAM-GFP) was linked to the actin
cortex, probably by the adaptor protein syntenin-1 (Fig. 1B). A
force stressing the ALCAM bonds pulled the stiff cortex and
plasma membrane outwards, whereas for ALCAM-DThr and
ALCAM-GPI, which could not attach to the cortex via syntenin-1,
only the plasma membrane was pulled outwards. The differences
between cell elasticities were small at contact times below 5 s but
increased with contact time (Fig. 5B). This time-dependent
increase was observed only for K562-ALCAM-WT cells and
K562-ALCAM-GFP cells, which correlates to the dynamic linking
of ALCAM to the actin cortex (Fig. 5B; supplementary material
Fig. S5A,B). Disruption of actin cortex linkages by the addition
of latrunculin A (LatA) reduced the elasticity of K562 cells
that express ALCAM-WT 1.6-fold and increased the number of
membrane tethers 1.9-fold (supplementary material Fig. S5C,D,E).
As expected, this disruption of the cortex decreases the
rupture forces of T-events from 35.569.8 pN to 21.766.9 pN
(mean6s.d.) (Sheetz, 2001; Sun et al., 2005).
ALCAM–CD6 bonds stiffen the actin cytoskeleton
Having determined that the elasticity of K562 cells depends on
which ALCAM construct is expressed, we questioned whether
such dependency is observed for the stiffness of the cell. Cell
stiffness can be quantified from the contact region of the
approach force–distance curve – i.e. while the cell is being
pressed against the much stiffer glass substrate (Fig. 1C). Cell
stiffness, or its ability to resist deformation, is strongly influenced
by the actin cytoskeleton (Schwarz and Gardel, 2012).
Comparison of the cell stiffness at the beginning of an SCFS
experiment and after sequential contact cycles with the CD6
substrate revealed that K562 cells expressing ALCAM-WT,
-GFP or -DThr increased stiffness significantly (Fig. 5C). By
contrast, cells expressing ALCAM-GPI and control K562 cells
did not change stiffness. Moreover, higher levels of cell adhesion
correlated slightly with higher levels of cell stiffness when
ALCAM constructs bound to CD6 (supplementary material Fig.
S5G). Thus, ALCAM-WT, ALCAM-GFP and ALCAM-DThr
might stiffen the actin cytoskeleton using an adaptor protein other
than syntenin-1 because ALCAM-DThr cannot link to it. A
probable candidate is ezrin (Fig. 1B; supplementary material Fig.
S2), which might directly, or through signaling, contribute to
ligand-induced stiffening of the actin cortex. Taken together,
these results suggest that the association of ALCAM with the
actin cortex, probably mediated by adaptor proteins, strengthens
adhesion by affixing ALCAM to a stiffening actin cortex.
DISCUSSION
Here, we explored how mutations in the cytoplasmic tail of
ALCAM affect the binding of ALCAM to the actin cortex. The
combination of SCFS and TIRFM, together with the new force–
distance curve analyses, enabled us to explore molecular
mechanisms of ALCAM–CD6-mediated cell adhesion. Our
primary finding is that linking ALCAM to the actin cortex
establishes and strengthens cell adhesion.
Earlier studies have demonstrated an association between
ALCAM and actin that affects the avidity but not the affinity of
ALCAM (Nelissen et al., 2000; Zimmerman et al., 2004; te Riet
et al., 2007). Our SCFS experiments confirmed that the affinity of
ALCAM for CD6 was unaffected upon linking ALCAM to the
actin cortex (Fig. 4). The unbinding rate of ALCAM–CD6-
anchored membrane tethers revealed an unbinding/dissociation
rate of<0.5 s21 for the ALCAM–CD6 bond. This value compares
well to the ALCAM–CD6 unbinding rate of 0.40–0.63 s21 which
had been determined by surface plasmon resonance in vitro
(Hassan et al., 2004). Our SCFS results further highlight that the
linking of ALCAM to actin modulates ALCAM avidity. Contact-
time-dependent force measurements of K562 cells that express
ALCAM and adhere to CD6 demonstrated that ALCAM is
recruited to the CD6 contact site within minutes but must first be
released from the actin cytoskeleton. ALCAM constructs with
deficient actin cortex linkage – ALCAM-DThr and ALCAM-GPI –
displayed recruitment to CD6 contact sites 2–3 times faster
(Fig. 2). From these observations we conclude that once ALCAM
binds to CD6, ALCAM re-links to the actin cortex, which further
strengthens cell adhesion (Fig. 6).
Fig. 6. Establishing and strengthening ALCAM–CD6-mediated
adhesion under tension. (A) When an ALCAM-expressing cell – e.g. a DC
– makes contact with a CD6-expressing cell – e.g. a T cell – ALCAM is
released from the actin cortex and recruited to CD6. Because ezrin and
syntenin-1 link the cytoplasmic tail of ALCAM to the actin cortex, they have to
release either ALCAM or the actin cortex to allow ALCAM recruitment. The
tetraspanin CD9 scaffolds microdomains of ALCAM using cis-interactions
with extracellular ALCAM domains. (B) When bound to CD6, a
supramolecular complex is rapidly formed, with the adaptor proteins ezrin
and syntenin-1 linking ALCAM to the actin cortex. Syntenin-1 strengthens
ALCAM–CD6 bonds by tightly affixing ALCAM to the cortex. Ezrin connects
ALCAM at a membrane proximal site to the cortex and is a possible target for
PKCa-mediated outside-in signaling under tension when weaker ezrin links
with ALCAM on the membrane are ruptured. The complementary roles of
syntenin-1 and ezrin in linking ALCAM to the actin cortex results in
strengthening adhesion with a lower probability to form tethers.
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The ALCAM-DThr construct used has a mutation that prevents
the binding of syntenin-1 to the PDZ-binding motif of the
cytoplasmic tail of ALCAM (Gimferrer et al., 2005; C. Tudor,
J.t.R., R. Harkes, J. S. Kanger, C.G.F. and A.C., unpublished).
The truncation of the cytoplasmic tail of ALCAM-GPI eliminates
the binding of adaptor proteins, such as ezrin and syntenin-1. The
loss of the association of these ALCAM constructs with syntenin-
1 and ezrin was confirmed in colocalization studies (Fig. 1B;
supplementary material Fig. S2), which agrees with previous
FRET-FLIM measurements (C. Tudor, J.t.R., R. Harkes, J. S.
Kanger, C.G.F. and A.C., unpublished). Moreover, syntenin-1
binding appeared unaffected by the presence of a C-terminal
eGFP tag, binding equally well to the altered C-terminal PDZ-
binding motif. Based on the observation that ALCAM-WT-,
-GFP- and -DThr-expressing K562 cells stiffened after binding to
CD6 (Fig. 5C), we concluded that ligand binding of these
ALCAM constructs affected the stiffness of the actin cytoskeleton.
These cells expressed ALCAM constructs that exposed the PCRD
in their cytoplasmic tail at the membrane proximal site (Fig. 1A).
The enrichment of phosphatidylinositol 4,5-bisphosphate (PIP2) at
PCRD sites supports initial ezrin binding that connects the cellular
membrane to the actin cortex (Hao et al., 2009). ERM proteins can
modulate the structure of the cell cortex, signal transduction
pathways and cellular stiffness (Fehon et al., 2010; Titushkin et al.,
2013). Interestingly, protein kinase C (PKC) isoforms – e.g. PKCa
– can influence ERM activities, by both altering their conformation
and changing their binding to interaction partners (Ng et al., 2001;
Larsson, 2006). Previous studies have shown that PKCa plays a
role in cytoskeleton-dependent avidity modulation of ALCAM
(Zimmerman et al., 2004). However, the cytoplasmic tail of
ALCAM is not a direct target of PKCa because it lacks PKC
phosphorylation motifs and the ability to be phosphorylated upon
PKC activation (Zimmerman et al., 2004). Our new insights
suggest that ezrin, which forms a supramolecular complex with
ALCAM, is regulated by PKCa (Fig. 6B) by a mechanism that
remains to be elucidated.
The ALCAM-DThr construct allows binding to ezrin but not
to syntenin-1 (Fig. 1B); therefore, the latter is not crucial for
PKCa-mediated signaling. Syntenin-1, which binds to the PDZ
motif of ALCAM and links ALCAM to the actin cortex, lowers
the elasticity of the actin cortex and thereby strengthens the
adhesion sites (Fig. 5A,B), to which the presence of ezrin
contributes only a minor part – illustrated by ALCAM-DThr.
Syntenin-1 can play a spatiotemporal regulatory role in actin
remodeling, as documented in CD4+ T cells during HIV-1
binding and entry (Gordo´n-Alonso et al., 2012). Syntenin-1
induced cellular polarization of the viral receptor and co-
receptor (CD4 and CXCR4, respectively) towards the virus
contact area, triggering local actin polymerization and PIP2
production (Gordo´n-Alonso et al., 2012). Furthermore, syntenin-
1 is essential for polarized actin structures in T cells, such as at
the leading edge and the immunological synapse, and stimulates
actin polymerization by activating the Rho-like GTPase Rac-1
(Sala-Valde´s et al., 2012). During homotypic ALCAM-mediated
cell adhesion, Rac-1 can be activated by the cytoskeleton-
disrupting agent cytochalasin D or latrunculin A (Zimmerman
et al., 2004). However, during these homotypic interactions
Rho-like GTPases have no role in cytoskeleton-dependent
avidity modulation of ALCAM (Zimmerman et al., 2004).
Whether Rac-1 is involved in heterotypic interactions of
ALCAM with CD6 is not known. Thus, there might exist an
unrecognized interplay between PKCa, Rac-1, syntenin-1 and
ezrin in regulating ALCAM–CD6-mediated adhesion at the
immunological synapse.
Tetraspanin CD9 was recently found to act as a scaffold in
tetraspanin-enriched microdomains containing ALCAM by
interacting with the extracellular Ig domain of ALCAM (Gilsanz
et al., 2013). In cells, all of our ALCAM constructs showed similar
ALCAM microdomain sizes of <0.2 mm2 and colocalized with
CD9 in K562 cells (supplementary material Fig. S2). Therefore,
CD9 organizes ALCAM at the plasma membrane independently of
actin cortical interactions (Fig. 6).
Membrane tethering is important for leukocytes and
neutrophils to roll along the endothelium, where integrin-a4b1–
VCAM-1 or P-selectin–PSGL-1 bonds anchor tethers (Grabovsky
et al., 2000; Sundd et al., 2012). Membrane tethers attach cells to
substrates over long distances (up to several 100 mm) and keep
the force applied at the attachment site constant. Thereby,
membrane tethers absorb energy and allow the cell to stall (Krieg
et al., 2008). Cells are able to regulate tethered bonds and tether
forces by altering the lipid composition of the membrane (Hong
et al., 2012) and by releasing or linking the plasma membrane to
the cytoskeleton. This linkage to the plasma membrane involves
transmembrane proteins and/or adaptor proteins, such as ERM
molecules (Sun et al., 2005; Krieg et al., 2008; Hao et al., 2009).
The new SCFS analysis processes applied in this study revealed
that membrane tethers are formed during ALCAM–CD6-
mediated cell adhesion and that <1 out of 6 (i.e. <16%)
ALCAM–CD6 bonds formed tethers. By combining TIRFM with
SCFS, we colocalized for the first time T-events in the force–
distance curve to the unbinding of membrane tethers that were
anchored by ALCAM–CD6 bonds (Fig. 3). When ALCAMs
could not link to the actin cortex, such as GPI-anchored ALCAM,
twice as many tethers formed (Fig. 4). We hypothesize that this
anchorage of ALCAM to the actin cortex is facilitated by
syntenin-1 and ezrin (Fig. 6). As demonstrated by the ALCAM-
DThr construct, the presence of ezrin might be sufficient to link
actin to the membrane (Krieg et al., 2008; Hao et al., 2009) via
ALCAM and to lower the probability of forming membrane
tethers (Figs 4, 6). Pulling membrane tethers from K562 cells that
expressed different ALCAM constructs required similar forces of
<37 pN at short contact times with CD6 (#5 s). This implies that
these membrane tethers have similar compositions (Sheetz, 2001;
Krieg et al., 2008). However, upon extending the contact times
with CD6 to .50 s, the force required to pull membrane tethers
increased (Fig. 4E), which is possibly attributable to stiffening of
the actin cortex, induced by ALCAM–CD6-binding and ezrin,
and the changing properties of the plasma membrane (Fig. 5C).
Whether ALCAM–CD6-mediated membrane tethering has a
functional role at DC–T-cell contacts is unknown.
In conclusion, our data support a model for ALCAM-mediated
adhesion to CD6 (Fig. 6). When a cell expressing ALCAM comes
into contact with CD6, ALCAM molecules in the plasma
membrane are released from the cortex and recruited to the
contact site. With an increasing time of contact with CD6,
ALCAM accumulates at the contact site and strengthens cell
adhesion by increasing avidity. Adhesion matures by affixing
ALCAM to the cell cortex in a process that is probably mediated
by syntenin-1, with a limited contribution to the total strength by
weaker ezrin linkages. However, by linking ALCAMs to the actin
cortex, ezrin lowers the probability that membrane tethers are
formed. When exposed to mechanical stress, ALCAM binding to
CD6 stiffens the cellular contact site, which is, speculatively,
controlled through ezrin-associated signaling. These findings
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increase our understanding of the mechanism of how ALCAM on
DCs contributes to the formation and stabilization of the
immunological synapse formed with T cells.
MATERIALS AND METHODS
Cell lines and cultures
Culture media, serum and antibiotics were purchased from Invitrogen
(Breda, The Netherlands). K562 cell lines that stably expressed
ALCAM-WT, ALCAM-GFP, ALCAM-DThr or ALCAM-GPI were
generated and maintained as described previously (Nelissen et al.,
2000; Zimmerman et al., 2004). Briefly, K562 cells growing in
suspension were cultured in a medium mixture [75% RPMI 1640
containing 10% fetal bovine serum (FBS) and 25% Iscove’s modified
Dulbecco’s medium containing 5% FBS] supplemented with 0.5%
antibiotic-antimycotic in a humidified atmosphere under 5% CO2 at
37 C˚. Cells were passaged every 3–4 days at 200,000 cells/ml and cells
were seeded at 400,000 cells/ml 16–24 h before measurements.
Substrates
Four different coatings were made on glass-bottomed dishes (35-mm Petri
dish, World Precision Instruments) using a 150-mm thick four-segment
polydimethylsilane (PDMS) mask that was fused to the glass directly after
treating the glass and mask for 30 s in a plasma cleaner/sterilizer (PDC-
32G, Harrick Plasma). PDMS masks were solvent cast from a 1:10 ratio
mixture of PDMS (Sylgard 184, Dow Chemical) on a 150-mm deep
custom-made aluminium mould with four 464 mm2 openings separated by
2 mm. The four different coatings were prepared using a three-step method
in the case of CD6-Fc- and ICAM-1-Fc-coatings (te Riet et al., 2007).
Briefly, glass dishes were incubated overnight at 4 C˚ with 10 mg/ml goat
anti-human-Fc (GaHuFc; Jackson ImmunoResearch) in TSM buffer
(20 mM Tris-HCl, 150 mM NaCl, 1 mM CaCl2, 2 mM MgCl2 at
pH 8.0). After washing with TSM buffer, the uncovered glass surface
was blocked with TSM buffer containing 2% BSA by incubating it for
30 min at 37 C˚, followed by washing with TSM. Finally, the glass surface
was incubated with 5 mg/ml recombinant human CD6-Fc chimera (R&D
Systems) or 5 mg/ml recombinant human ICAM-1-Fc in TSM. For coating
with GaHuFc, the final step was skipped and for BSA-coating only a 2%
BSA containing TSM solution was used.
Single-cell force spectroscopy
SCFS using living cells was performed using an atomic force microscope
(Nanowizard II with CellHesion Module, JPK Instruments) mounted
on an inverted microscope (Observer.Z1, Zeiss). The temperature was
maintained at 37 C˚ throughout the experiment by a Petri dish heater (JPK
Instruments) with a set-point at 38 C˚. Cells were attached to tip-less AFM
cantilevers (NP-O, Bruker) coated with concanavalin A (ConA) (Sigma)
(Friedrichs et al., 2010). ConA-coated cantilevers were prepared as
follows: cantilevers were cleaned by immersion in pure 18 M sulphuric
acid (Sigma) for 1 h and then thoroughly rinsed with Milli-Q water
followed by ethanol and, after a final rinse in Milli-Q water, left to dry.
Following an overnight incubation at 4 C˚ in ConA (2 mg/ml in PBS), the
cantilevers were rinsed and stored in PBS for no more than 1 day. The
spring constant of each cantilever was calibrated before cell attachment
using thermal noise analysis (te Riet et al., 2011).
To adhere a single cell to the AFM cantilever, cells were seeded from
suspension in the perfusion chamber in culture medium without FBS
but with 0.5% antibiotic-antimycotic at pH 7.4 (+10 mM HEPES). The
ConA-coated cantilever was pushed softly (,3 nN) onto the cell for
<10 s. Upon retraction of the cantilever, the detachment of the cell was
monitored by using DIC microscopy. Thereafter, the cell was allowed to
adhere strongly to the cantilever for 5–10 min. When cells (partly)
detached from the cantilevers during experiments, cantilevers and data
were discarded. Adhesion of the cantilever-bound cell to different
substrates was measured after pushing the cell into contact with the
substrate, applying 2 nN for predefined time intervals (0.5–120 s).
Subsequently, the cell was retracted at 5 mm/s and allowed to recover for
a time period equal to that of the contact time with the substrate
(Friedrichs et al., 2010). The sequence of contact time measurements was
varied and performed in two subsequent series on different areas of
the substrate. The number of cells (NC) measured and force–distance
curves (NFD) analyzed are detailed. Supplementary material Table S1
summarizes these numbers for every experiment.
Combined TIRFM-SCFS
TIRFM was performed using an inverted microscope (Observer.Z1, Zeiss)
fitted with an AFM-based SCFS (CellHesion 200, JPK Instruments) and a
1006NA1.45 aPlan-FLUOR objective (Zeiss). TIRFM illumination was
achieved through coupling a beam emitted by a solid-state laser (Sapphire
488 LP, 50 mW, Coherent) into a single mode fiber (coupler, HPUC-2-
488-4.5AS-11; fiber, QPMJ-A3A, 3S-488-3.5/125-SAS-4, OZ Optics)
connected to a slider TIRFM condenser (Laser TIRF, Zeiss). A TIRFM that
had been optimized with fluorescein isothiocyanate (FITC) filter sets
(Chroma Technology Corp.) was used. Images were recorded by using a
digital camera (AxioCam MRm, Zeiss) and imaging software (Axiovision,
Zeiss). SCFS using ALCAM-GFP-expressing cells was conducted as
described above. Before starting SCFS, we acquired FITC-TIRFM images
at 5 frames/s. TIRFM images were acquired during the approach, contact
and retract phase of one SCFS cycle.
Confocal laser scanning microscopy
To colocalize ALCAM with syntenin-1, ezrin, actin and CD9, cells were
stained with antibodies against ALCAM (AZN-L50), syntenin-1 (rabbit
anti-human polyIgG, sc-48742, Santa Cruz Biotechnology), ezrin (goat anti-
human polyIgG, sc-6409, Santa Cruz Biotechnology), actin (phalloidin–
Texas-Red, Invitrogen) and CD9 (mouse anti-human monoIgG1k; catalog
number 555370, BD Pharmingen). Isotype-specific controls were always
included. Analysis was performed with a confocal laser scanning
microscope (CLSM, Leica LS5) using a 636NA1.40 oil HCX PL APO
objective. Signals were collected sequentially to avoid bleed through. Cells
were harvested and stained with a 10 mg/ml concentration of antibody
against ALCAM (AZN-L50) – with 5 mg/ml of antibody against CD9 for
specific samples – at 4 C˚, after prolonged incubation in CLSM buffer (PBS,
3% BSA, 10 mM glycine) to minimize unspecific binding. Patching was
induced by incubation at 12 C˚ for 1 h. After removing unbound antibodies
by extensive washing in ice-cold PBS, cells were quickly fixed in 2%
paraformaldehyde (PFA) and, after a blocking step in CLSM buffer and
permeabilization with 0.5% Triton in PBS for 5 min, secondary staining for
syntenin-1 and ezrin was performed using isotype-specific Alexa-Fluor-647-
conjugated rabbit and goat anti-mouse antibodies (Invitrogen); actin
was stained by phalloidin. Manders coefficients were calculated using the
plug-in JACoP in ImageJ (http://rsb.info.nih.gov/ij/) and reflects the
amount of ALCAM colocalizing with syntenin-1, ezrin, actin or CD9 for
each cell.
Data processing
Detachment forces were determined after baseline correction of force–
distance curves with JPK software. Force-step analysis, force–distance
curve averaging, and cell stiffness were determined from force–distance
curves using in-house Igor Pro 6 (WaveMetrics) algorithms. Detachment
forces and T-events were statistically analyzed using OriginPro 8. One-
phase exponential associate curves [y5y0 + AN(12exp(2t/tK))] were fitted
to time-dependent detachment force and tethering curves. Exponential
decay curves [y5y0 + ANexp(2t/tK)] to cumulated lifetimes (distance
divided by retraction rate) were fitted using OriginPro 8. Mean extraction
force histograms were fitted by a Gaussian function giving maximum and
sigma (s equals s.d.). The cell cortex stiffness was determined using
approach force–distance curves in which the cell is compressed between
the cantilever and glass substrate. Therefore, approach force–distance
curves were converted into force-indentation (F-d) curves and fitted over
the linear contact region (force range 0.2–1.5 nN, Fig. 1D) resulting in the
resistance to deformation of the cell. Significances were determined by
Mann–Whitney U statistical tests by using GraphPad Prism 5.
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Supplementary Figure S1: Set-up of SCFS experiments with K562 cells expressing ALCAM-constructs. (A) Combined DIC-fluorescence 
(green) microscopy image of an ALCAM-GFP-expressing K562 cell adhering to the apex of an AFM cantilever. (B) 63x confocal laser 
scanning microscopy (CLSM) image of homogenous CD6-Fc and control coatings: (i) BSA (upper left; gray) by directly labelled BSA-Al-
exa488 (Invitrogen), (ii) GaHuFc (upper right; green) - first step of making the 2-step CD6-Fc coating - by using biotinylated-GaHuFc 
(Jackson Immuno Research) stained with streptavidin-Alexa488 (Invitrogen), (iii) ICAM-1-Fc (lower left; blue) - similar ligand as CD6-Fc, 
however, for which receptors are not expressed by K562 cells - stained by using conjugated ICAM-1-Fc with Alexa568, and (iv) CD6-Fc 
(lower right; red) stained with anti-CD6 (mouse-anti-human IgG1; BD Pharmingen) and goat-anti-mouse-IgG1-Alexa488 (Invitrogen). 
(C) Representative SCFS F-D curves of a K562-ALCAM-WT cell after being in contact for 10 sec with three different control substrates 
(BSA, GaHuFc, and ICAM-1-Fc) and with the ALCAM-specific substrate CD6-Fc. (D) Fluorescence-activated cell sorting (FACS) analysis 
of ALCAM expression in K562 cells stably transfected with ALCAM-WT, ALCAM-GFP, ALCAM-ΔThr, ALCAM-GPI, and control K562 cells. 
Cells were stained by the mouse monoclonal IgG2a anti-ALCAM antibody AZN-L50 and goat-anti-mouse-IgG (H&L)-Alexa647 (Invit-
rogen). Control K562 cells have no endogenous expression of ALCAM. For each cell the expression of the ALCAM-construct is given 
in %. Mean fluorescence intensities are 15×10³ (K562-ALCAM-WT), 50×10³ (K562-ALCAM-GFP), 75×10³ (K562-ALCAM-ΔThr), 45×10³ 
(K562-ALCAM-GPI), and 75 (K562). (E) Average SCFS F-D curves of K562 cells expressing ALCAM-WT, -GFP, -ΔThr, -GPI, or control cells 
after being in contact for 10 s with CD6-Fc, BSA, GaHuFc, or ICAM-1-Fc coated substrates. F-D curves were aligned at the maximum 
detachment force and averaged (number of FD curves average NFD between brackets). Specific ALCAM-CD6-mediated cell adhesion can 
be clearly distinguished from the BSA, GaHuFc, and ICAM-1-Fc controls.
A
Suppl. Figure S1
B
50 µm
10 µm
CBSA GaHuFc
ICAM-1-Fc CD6-Fc
10 µm
10 µm
10 µm
102 103 104 105
Fluorescence of Alexa647
102 103 104 105
Fluorescence of Alexa647
20
0
15
0
10
0
50
0
Co
un
ts 2
00
15
0
10
0
50
0
Co
un
ts
25
0
K562-ALCAM-WT
87%
K562-ALCAM-GFP
99% 30
0
20
0
10
0
0
Co
un
ts
102 103 104 105
Fluorescence of Alexa647
102 103 104 105
Fluorescence of Alexa647
15
0
10
0
50
0
Co
un
ts
K562-ALCAM-∆Thr
K562-ALCAM-GPI
100%
94%
20
0
15
0
10
0
50
0
Co
un
ts
25
0
102 103 104 105
Fluorescence of Alexa647
K562
0%
D
E
Supplementary Figure S2: Immunofluorescent labeling of actin, syntenin-1, ezrin, and CD9 analyzed by CLSM. (A) K562 cells express-
ing ALCAM-WT, ALCAM-GFP, ALCAM-ΔThr, and ALCAM-GPI were co-labeled with the antibody AZN-L50 to ALCAM and phalloidin (Invi-
trogen) to actin, rabbit-anti-human polyIgG anti-syntenin-1 (sc-48742; Santa Cruz), goat-anti-human polyIgG anti-ezrin (sc-6409; Santa 
Cruz), or mouse-anti-human monoIgG1κ anti-CD9 (#555370; BD Pharmingen). (B) Quantification of the colocalization between ALCAM 
and actin, ALCAM and syntenin-1, ALCAM and ezrin, as well as ALCAM and CD9 represented by Manders’ coefficients (C) CLSM image 
of ALCAM microclusters at the basal site of 2% paraformaldehyde (PFA) pre-fixed K562 cells expressing ALCAM-WT, -GFP, -ΔThr, and 
-GPI. (D) Quantification of cluster sizes show non-significant differences by ANOVA; mean areas ± s.d. are 0.19 ± 0.24 µm² (ALCAM-WT), 
0.19 ± 0.18 µm² (ALCAM-GFP), 0.22 ± 0.24 µm² (ALCAM- ΔThr), and 0.15 ± 0.16 µm² (ALCAM-GPI) (N ≥ 42). Scale bars indicate 5 µm. 
(*** p<0.0001; n.s., not significant).
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Supplementary Figure S3: Combined TIRFM-SCFS imaging. (A) Full series of stills of TIRFM images (from Suppl. Movie 1A) recorded 
while retracting a K562-ALCAM-GFP cell from a CD6-Fc coating. The release of tethers as simultaneously observed in the TIRFM stills 
and force-time curve (Fig. 3A) is indicated by numbered arrows. (B) Zoom ins to the force time curve showing the rupture steps with 
rupture force attributed to tether ruptures by TIRFM.
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Supplementary Figure S4: Correlations between detachment force vs probing cycle, detachment force vs amount of tethers, and 
tether extraction force vs contact time. (A) Detachment forces show no trends depending on probing cycle. The detachment forces of 
a series of 47 F-D curves (NFD = 47) for a K562-ALCAM-GPI cell interacting with a CD6-coating for different contact times were normal-
ized to the average detachment forces per contact time. The relative changes within small contact time series (NFD ≥ 3; first measure-
ment per series indicated by *) are random. This is also clear for a longer series of NFD = 9 measurement at a contact time of 50 sec 
(indicated in graph). Because no lowering trends are visible in the series, we concluded that ALCAM-GPI molecules on cellular mem-
branes of K562 cells are not pulled from these membranes. (B) Correlation plots between detachment force and amount of tethers. 
The correlation between the amount of tethers and detachment force is plotted for a contact time of 50 sec for K562 cells expressing 
ALCAM-WT, ALCAM-GFP, ALCAM-ΔThr, ALCAM-GPI, and control K562 cells. Cell adhesion was measured to CD6-Fc-coated substrates. 
Pearson correlation coefficients are given with significance values (p) and are rather low - Pearson assumes linearity. Dotted lines rep-
resent a best fit for a hypothetical linear relation. (C) Tether extraction force histograms of tether events at contact times from 0.5 to 
120 sec for all K562 cells expressing ALCAM-constructs or none. Distributions shift to higher forces upon increasing interaction times; 
maximum of distributions and Gaussian fits are given. In histograms for K562-ALCAM-GPI cells secondary peaks of double ruptures are 
indicated by arrows; Gaussian fits of two peaks at 36.5 and 73 pN are given with % contribution second peak.
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Supplementary Figure S5: Influence of linking ALCAM to the actin cortex on averaged F-D curve, elasticity and cell stiffness. (A) 
Averaged F-D curves at different contact times with a CD6-Fc coating. F-D curves of K562 cell expressing ALCAM-WT, ALCAM-GFP, 
ALCAM-ΔThr, ALCAM-GPI, and no ALCAM interacting with CD6-Fc substrate were averaged by aligning the F-D curves (NFD between 
brackets) at maximum detachment force. The increase in detachment force at increasing contact times is clearly seen by deeper curves. 
The increase in tethering can be seen as widening of the F-D curves, which is most clear for ALCAM-GPI expressing cells. (B) Comparison 
of averaged F-D curves at contact time shows difference between cells expressing different ALCAM-constructs. (C-F)  Influence of the 
actin cortex on the elasticity and membrane tethering of a K562 cell expressing ALCAM-WT. The interaction of K562-ALCAM-WT cells 
with a CD6-Fc substrate for 2 sec was measured before and after addition of 0.2 µM LatA for 30 minutes, by a Bruker Catalyst AFM 
(mean ± s.d.; NFD ≥ 40; NC = 3; *** p>0.0001). (C) Representative SCFS F-D curves showing a curve before and after treatment with actin 
cortex disrupting drug latrunculin A (LatA). (D) Box-whisker plot analysis of the elasticity shows that the treatment by LatA lowered the 
elasticity 1.6× from 2.84 ± 0.367 nN/µm to 1.77 ± 0.38 nN/µm (+ indicates mean). (E) The number of membrane tethers per retraction 
increased 1.9× from 0.97 ± 0.93 to 1.86 ± 1.03 after treatment. (F) The rupture force of the tether events (N > 60) decreased from 34.4 
± 9.8 pN to 23.2 ± 6.7 pN after treatment (G) Correlation between detachment force and cell stiffness. The cell stiffness and detach-
ment force measured by SCFS is plotted for a contact time of 50 sec for K562 cells expressing ALCAM-WT, ALCAM-GFP, ALCAM-ΔThr, 
ALCAM-GPI, and no ALCAM. The cells were brought in contact with CD6-Fc substrates. The Spearman correlation coefficients are given, 
in the case of cells expressing ALCAM-WT, -GFP, and -ΔThr the correlation is >0.2 and significant (p<0.05). Dotted lines represent a best 
fit for a hypothetical linear relation; Spearman correlation assumes also non-linearity.
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Supplementary Movie 1: Detachment of a K562-ALCAM-GFP cell from CD6 imaged by AFM-TIRFM. Movie of TIRFM images recorded 
while retracting a K562 cell expressing ALCAM-GFP immobilized on an AFM cantilever. Before retracting, the cell interacted for 5 sec 
with a CD6-Fc substrate. Time point 0 indicates the starting point of the retraction of the cell. The unbinding of tethers, observed as the 
loss of fluorescence in TIRFM, is correlated to the force-time curve shown in Fig. 3A in an animation. 
Supplementary Movie 2: The unbinding of the cellular body and membrane tethers of a K562-ALCAM-GFP cell. Upon retraction of a 
K562 cell expressing ALCAM-GFP after 10 sec contact time with a CD6-Fc-substrate “networks” of tethers are stretched and unbound. 
The loss of fluorescence in TIRFM coincides with T-events in SCFS F-D curves. Time point 0 indicates the starting point of the retraction 
of the cell. (A) Light sensitivity adapted for observation of the cellular body in contact with the substrate. (B) Light sensitivity adapted 
for observation of the tethers unbinding from the substrate.
Supplementary Movie 3: As supplementary Movie 2 but the light sensitivity was adapted for observation of the tethers unbinding from 
the substrate.
Table S1 
Experiment  Type  K562‐ALCAM‐WT  K562‐ALCAM‐GFP  K562‐ALCAM‐ΔThr  K562‐ALCAM‐GPI  Control K562 cells 
De
ta
ch
m
. fo
rc
e 
CD
6 v
s c
on
tr
ol
s 
[F
ig
. 2B
] 
BSA  76 [16]  56 [10]  46 [10]  110 [19]  39 [10] 
GaHuFc  53 [10]  55 [10]  40 [10]  76 [16]  34 [8] 
ICAM‐1‐Fc  52 [12]  55 [10]  57 [10]  97 [19]  40 [10] 
CD6‐Fc  82 [13]  53 [10]  57 [10]  57 [10]  54 [10] 
De
ta
ch
m
en
t fo
rc
e 
Co
nt
ac
t ti
m
e 
[F
ig
. 2C
,D
,E
] 
0.5 sec  50 [11]  51 [10]  57 [10]  55 [10]  49 [10] 
2 sec  60 [11]  48 [10]  60 [10]  55 [10]  49 [10] 
5 sec  62 [11]  50 [10]  62 [10]  54 [10]  47 [10] 
10 sec  82 [13]  53 [10]  59 [10]  57 [10]  54 [10] 
20 sec  66 [11]  53 [10]  59 [10]  53 [10]  51 [10] 
50 sec  78 [13]  52 [10]  59 [10]  55 [10]  52 [10] 
120 sec  35 [10]  39 [10]  34 [10]  40 [10]  45 [10] 
Te
th
er
s p
er
 re
tr
. 
CD
6 v
s c
on
tr
ol
s 
[F
ig
. 4B
] 
BSA  76 [16]  56 [10]  46 [10]  110 [19]  39 [10] 
GaHuFc  53 [10]  55 [10]  40 [10]  76 [16]  34 [8] 
ICAM‐1‐Fc  52 [12]  55 [10]  57 [10]  97 [19]  40 [10] 
CD6‐Fc  77 [13]  54 [10]  62 [10]  63 [10]  49 [10] 
Te
th
er
s p
er
 re
tr
ac
tio
n 
Co
nt
ac
t ti
m
e 
[F
ig
s 4
A,
C &
 S4
B]
 
0.5 sec  49 [11]  54 [10]  57 [10]  53 [10]  45 [10] 
2 sec  62 [11]  51 [10]  60 [10]  56 [10]  46 [10] 
5 sec  62 [11]  54 [10]  62 [10]  54 [10]  45 [10] 
10 sec  77 [13]  54 [10]  62 [10]  63 [10]  49 [10] 
20 sec  68 [11]  54 [10]  61 [10]  52 [10]  46 [10] 
50 sec  80 [13]  54 [10]  60 [10]  58 [10]  46 [10] 
120 sec  34 [10]  41 [10]  39 [10]  39 [10]  40 [10] 
Te
th
er
s ru
pt
ur
e s
te
ps
* 
Co
nt
ac
t ti
m
e 
[F
ig
s 4
D,
E &
 S4
C]
 
0.5 sec  65  53  96  153  16 
2 sec  106  100  152  351  43 
5 sec  205  211  275  517  75 
10 sec  475  283  457  848  141 
20 sec  535  409  588  940  197 
50 sec  889  628  723  1290  278 
120 sec  489  545  459  999  287 
Av
er
ag
e c
ur
ve
s 
CD
6 v
s c
on
tr
ol
s 
[F
ig
s 2
A&
S1
E]
  BSA  76 [13]  56 [10]  46 [10]  46 [10]  39 [10] 
GaHuFc  53 [10]  55 [10]  40 [10]  40 [10]  34 [8] 
ICAM‐1‐Fc  52 [12]  55 [10]  57 [10]  57 [10]  40 [10] 
CD6‐Fc  66 [13]  53 [10]  59 [10]  57 [10]  54 [10] 
Av
er
ag
e F
‐D 
cu
rv
es
 
Co
nt
ac
t ti
m
e 
[F
ig
s 5
A,
C &
 S5
A,
B]
 
0.5 sec  50 [11]  51 [10]  57 [10]  55 [10]  49 [10] 
2 sec  60 [11]  48 [10]  60 [10]  55 [10]  46 [10] 
5 sec  62 [11]  50 [10]  62 [10]  54 [10]  47 [10] 
10 sec  66 [13]  53 [10]  59 [10]  57 [10]  54 [10] 
20 sec  66 [11]  53 [10]  59 [10]  53 [10]  51 [10] 
50 sec  64 [13]  52 [10]  59 [10]  55 [10]  52[10] 
120 sec  35 [10]  39 [10]  34 [10]  40 [10]  45 [10] 
Table S1: Overview of the amount of F‐D curves analyzed per figure. The numbers represent the amount of F‐D curves used and amount of cells (between 
square brackets) that were analyzed for the data presented in the figures given in the left column. Overall, the same data set was analyzed and presented in 
all figures. *The number of steps is given that belong to the amount of F‐D curves and cells given in the list above (Tethers per retraction). 
 
